Innospec (NASDAQ:IOSP) Hits New 52-Week Low – Time to Sell?

Innospec Inc. (NASDAQ:IOSP) hit a new 52-week low on Monday . The company traded as low as $69.25 and last traded at $69.56, with a volume of 29580 shares traded. The stock had previously closed at $72.11.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on IOSP shares. Zacks Research lowered shares of Innospec from a “hold” rating to a “strong sell” rating in a report on Thursday, February 19th. Weiss Ratings upgraded Innospec from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, February 19th. Finally, Wall Street Zen raised Innospec from a “hold” rating to a “buy” rating in a research note on Saturday, December 13th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce”.

Innospec Stock Down 1.2%

The stock’s fifty day moving average price is $80.55 and its 200-day moving average price is $78.68. The company has a market capitalization of $1.75 billion, a price-to-earnings ratio of 15.09, a P/E/G ratio of 1.88 and a beta of 0.90.

Innospec (NASDAQ:IOSP) last announced its quarterly earnings data on Tuesday, February 17th. The specialty chemicals company reported $1.50 EPS for the quarter, beating analysts’ consensus estimates of $1.26 by $0.24. The company had revenue of $455.60 million during the quarter, compared to the consensus estimate of $460.87 million. Innospec had a net margin of 6.56% and a return on equity of 10.18%. The company’s quarterly revenue was down 2.4% on a year-over-year basis. During the same quarter last year, the firm posted $1.41 EPS. Analysts anticipate that Innospec Inc. will post 6.18 EPS for the current year.

Insiders Place Their Bets

In other Innospec news, Director Larry Padfield sold 1,030 shares of the business’s stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $81.84, for a total transaction of $84,295.20. Following the transaction, the director owned 8,508 shares of the company’s stock, valued at $696,294.72. The trade was a 10.80% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Milton C. Blackmore sold 1,030 shares of the company’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $81.84, for a total value of $84,295.20. Following the completion of the sale, the director owned 9,585 shares in the company, valued at $784,436.40. This represents a 9.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 4,989 shares of company stock worth $391,889. Company insiders own 1.31% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the stock. EverSource Wealth Advisors LLC lifted its position in Innospec by 1,159.5% during the second quarter. EverSource Wealth Advisors LLC now owns 529 shares of the specialty chemicals company’s stock worth $44,000 after purchasing an additional 487 shares during the period. Versant Capital Management Inc raised its position in shares of Innospec by 378.1% in the 3rd quarter. Versant Capital Management Inc now owns 545 shares of the specialty chemicals company’s stock valued at $42,000 after buying an additional 431 shares in the last quarter. Hantz Financial Services Inc. lifted its holdings in shares of Innospec by 271.0% during the 4th quarter. Hantz Financial Services Inc. now owns 575 shares of the specialty chemicals company’s stock worth $44,000 after acquiring an additional 420 shares during the period. Allworth Financial LP boosted its position in shares of Innospec by 31.0% during the 3rd quarter. Allworth Financial LP now owns 588 shares of the specialty chemicals company’s stock worth $45,000 after acquiring an additional 139 shares in the last quarter. Finally, Danske Bank A S acquired a new stake in shares of Innospec during the 3rd quarter worth approximately $46,000. Institutional investors and hedge funds own 96.64% of the company’s stock.

Innospec Company Profile

Innospec Incorporated (NASDAQ: IOSP) is a global specialty chemicals company headquartered in Cleveland, Ohio. The company operates through three principal business segments: Fuel Specialties, Oilfield Services, and Performance Chemicals. In the Fuel Specialties segment, Innospec develops and supplies additives designed to enhance octane levels, improve combustion efficiency, reduce emissions and prevent deposit formation in gasoline and diesel engines. Its Oilfield Services division provides chemical technologies—such as surfactants, corrosion inhibitors and demulsifiers—to support exploration, drilling, production optimization and enhanced oil recovery operations.